Journals / İstanbul Tıp Fakültesi Dergisi / 2020 / Cilt: 83 - Sayı: 3

THE IMPORTANCE OF HYDRADENITIS SUPURATIVA IN RHEUMATOLOGIC DISEASES

ROMATOLOJİK HASTALIKLARDA HİDRADENİTİS SÜPÜRATİVA’NIN ÖNEMİ

Pages
275–279
Publication Date
2020-06-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, a differential diagnosis should be made in patients followed up with the diagnosis of HS in the case of rheumatologic complaints.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Hidradenitis suppurativa (HS) is a recurrent chronic inflammatory disease of the apocrine glands.
📊
Key Findings & Data:Material and Methods: This study was performed retrospectively in the Department of Rheumatology between January 2017 and December 2018.
💡
Conclusion & Impact:Therefore, a differential diagnosis should be made in patients followed up with the diagnosis of HS in the case of rheumatologic complaints.
🔬Design:Research Article
📍Scope:2017 Verileri
⚙️Variables:Hidradenitis süpürativa · Spondiloartrit · Behçet hastalığı

Abstract

Objective: Hidradenitis suppurativa (HS) is a recurrent chronic inflammatory disease of the apocrine glands. It is more common in women, especially after puberty. The primary locations affected are the axillary, inguinal, perianal, and perineal regions, with a painful nodüle and a complex of symptoms ranging from abscesses to sinus formation and hypertrophic scars. Obesity and metabolic syndrome, especially spondyloarthritis, autoinflammatory diseases and some autoimmune diseases are more common in HS patients. In this study, we aimed to determine the etiologic factors, demographic and clinical characteristics of patients with HS who were attending our rheumatology clinic. Material and Methods: This study was performed retrospectively in the Department of Rheumatology between January 2017 and December 2018. Eleven patients diagnosed with HS and over 18 years of age were included in the study. Epidemiological, clinical, and laboratory findings, along with treatment information file records of patients, were obtained through examinations. Results: Of 11 patients diagnosed with HS, 10 were male and one was female. The mean age of the patients was 40.9 years (minumum 22, maximum 57). When evaluated for concomitant rheumatologic diseases, four cases of spondyloarthritis, three of Behcet’s disease, one of Familial Mediterranean Fever, one of rheumatoid arthritis, one of gout and one of SAPHO syndrome (synovitis, acne, pustulosis, hyperostosis and osteitis) were diagnosed. Conclusion: HS may be associated with rheumatic diseases. Therefore, a differential diagnosis should be made in patients followed up with the diagnosis of HS in the case of rheumatologic complaints.

Özet

Amaç: Hidradenitis suppurativa (HS), özellikle puberte sonrası, kadınlarda daha sık görülen apokrin glandların tekrarlayıcı kronik inflamatuar bir hastalığıdır. Primer tutulum bölgeleri aksiller, inguinal, perianal, perineal bölgeler olan hastalık, ağrılı bir nodülden, abse, sinüs oluşumu ve hipertrofik skarlara kadar değişen bir semptom kompleksinden oluşur. Başta obezite ve metabolik sendrom olmak üzere, spondiloartrit, otoinflamatuar hastalıklar ve bazı otoimmün hastalıklar HS hastalarında daha sık görülür. Bu çalışmamızda romatoloji kliniğimizde takipli olan ve HS tanısı almış hastalarda etyolojik, demografik ve klinik özelliklerin belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Bu çalışma retrospektif olarak Ocak 2017-Aralık 2018 tarihleri arasında Romatoloji Bilim Dalında yapıldı. Çalışmaya 18 yaş üzeri HS tanısı konulan 11 hasta dahil edildi. Hastaların epidemiyolojik, klinik, laboratuvar bulguları ve tedavi bilgileri dosya kayıtları incelenerek elde edildi. Bulgular: HS tanısı alan 11 hastanın 10’u erkek, biri kadındı. Hastaların ortalama yaşı 40,9 (en küçük 22-en büyük 57). Eşlik eden romatolojik hastalıklar açısından değerlendirildiğinde, dört seronegatif spondiloartropati, üç Behçet hastalığı, bir Ailevi Akdeniz Ateşi, bir romatoid artrit, bir gut ve bir SAPHO sendromu (sinovit, akne, püstüloz, hiperostoz ve osteit) tanıları mevcuttu. Sonuç: HS’nin romatizmal hastalıklarla birlikteliği gözlenebilir. Bu nedenle HS tanısı ile izlenen hastalarda romatolojik yakınmalar olduğunda tetkik edilerek ayırıcı tanı yapılmalıdır.

🔖

Cite This Article

TEZCAN, D., LİMON, M., GÜLCEMAL, S., YILMAZ, S. (2020). THE IMPORTANCE OF HYDRADENITIS SUPURATIVA IN RHEUMATOLOGIC DISEASES. İstanbul Tıp Fakültesi Dergisi, Cilt: 83 - Sayı: 3, 275–279. https://ajindex.com/articles/48038

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Sellheyer K, Krahl D. “Hidradenitis suppurativa” is acne inversa! An appeal to (finally) abandon a misnomer. Int J Dermatol 2005;44(7):535-40
  2. Jemec GB, Kimball AB. Hidradenitis suppurativa: epidemiology and scope of the problem. J Am Acad Dermatol 2015;73:4-7
  3. Molina-Leyva A, Cuenca-Barrales C. Adolescent-Onset Hidradenitis Suppurativa: Prevalence, Risk Factors and Disease Features. Dermatology 2019;235(1):45-50
  4. Revuz JE, Jemec GB. Diagnosing hidradenitis suppurativa. Dermatol Clin 2016;34(1):1-5
  5. Canoui-Poitrine F, Le Thuaut A, Revuz JE, Viallette C, Gabison G, Poli F, et al. Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a crosssectional study. J Invest Dermatol 2013;133(6):1506-11
  6. Vinkel C, Thomsen SF. Hidradenitis Suppurativa: Causes, Features, and Current Treatments. J Clin Aesthet Dermatol. 2018;11(10):17-23
  7. Pescitelli L, Ricceri F, Prignano F. Hidradenitis suppurativa and associated diseases. G Ital Dermatol Venereol 2018;153(3 Suppl 2):8-17
  8. Chiricozzi A, Giovanardi G, Caposiena Caro DR, Iannone M, De Simone C, Cannizzaro MV, et al. Characterization of comorbid conditions burdening hidradenitis suppurativa: a multicentric observational study. G Ital Dermatol Venereol 2018 Oct 3
  9. Tricarico PM, Boniotto M, Genovese G, Zouboulis CC, Marzano AV, Crovella S. An integrated approach to unravel Hidradenitis Suppurativa etiopathogenesis. Front Immunol 2019;10:892
  10. Kelly G, Hughes R, McGarry T, van den Born M, Adamzik K, Fitzgerald R, et al. Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa. Br J Dermatol 2015;173(6):1431-9
  11. Miller IM, McAndrew RJ Hamzavi I. Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatol Clin 2016;34(1):7-16
  12. Nikolakis G, Kyrgidis A, Zouboulis CC. Is There a Role for Antiandrogen Therapy for Hidradenitis Suppurativa? A Systematic Review of Published Data. Am J Clin Dermatol 2019;20(4):503-13
  13. Kelly G, Prens EP. Inflammatory mechanisms in hidradenitis suppurativa. Dermatol Clin 2016;34(1):51-8
  14. Phan K, Charlton O, Smith SD. Hidradenitis suppurativa and metabolic syndrome-systematic review and adjusted metaanalysis. Int J Dermatol. 2019;58(10):1112-1117
  15. Puig L, Ruiz de Morales JG, Dauden E, Andreu JL, Cervera R, Adán A, et al. Prevalence of ten Immune-mediated inflammatory diseases (IMID) in Spain. Rev Esp Salud Publica. 2019 Mar 25;93. pii: e201903013
  16. Rondags A, Aren